HealthShares family of exchange traded funds (ETFs) may appeal to investors who are monitoring the latest information regarding uninsured cancer patients. Uninsured cancer patients are twice as likely to die within 5 years, compared to those with private coverage. This is the first study of this type and unveils the troubling health care obstacles faced in this nation, reports Mike Stobbe for Associated Press.

It turns out people who don’t have health insurance are not likely to get recommended for cancer screening tests, making the time of diagnosis untimely, as the cancer may have already spread. An analysis says around 4% of the uninsured are accounting for the cancer-related deaths.

Related ETFs are:

  • HealthShares Cancer (HHK)
  • HealthShares Diagnostics (HHD)
  • HealthShares Enabling Technologies (HHV)

The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.

Subscribe to our free daily newsletters!
Please enter your email address to subscribe to ETF Trends' newsletters featuring latest news and educational events.